Decon-A Interactions
There are 474 drugs known to interact with Decon-A (brompheniramine/phenylephrine), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 37 are major, 435 are moderate, and 2 are minor.
- View all 474 medications that may interact with Decon-A
- View Decon-A alcohol/food interactions (1)
- View Decon-A disease interactions (8)
Most frequently checked interactions
View interaction reports for Decon-A (brompheniramine / phenylephrine) and the medicines listed below.
- acetaminophen
- Allergy Multi-Symptom (acetaminophen / chlorpheniramine / phenylephrine)
- aluminum hydroxide
- aluminum hydroxide / magnesium hydroxide / simethicone
- amoxicillin / clavulanate
- aripiprazole
- aspirin
- B Complex 100 (multivitamin)
- budesonide nasal
- Calcitrate with D (calcium / vitamin d)
- carisoprodol
- Chelated Magnesium (magnesium amino acids chelate)
- clotrimazole topical
- Concerta (methylphenidate)
- cyclobenzaprine
- Cymbalta (duloxetine)
- dexchlorpheniramine
- dextromethorphan / guaifenesin
- diclofenac
- ibuprofen
- itraconazole
- losartan
- magnesium glycinate
- modafinil
- naproxen
- prednisone
- Pseudoephedrine Sinus (acetaminophen / pseudoephedrine)
- simethicone
- sodium bicarbonate
- sulfamethoxazole / trimethoprim
Decon-A alcohol/food interactions
There is 1 alcohol/food interaction with Decon-A (brompheniramine / phenylephrine).
Decon-A disease interactions
There are 8 disease interactions with Decon-A (brompheniramine / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
Report options
QR code containing a link to this page
More about Decon-A (brompheniramine / phenylephrine)
- Decon-A consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.